• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem High Test Results (2457)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 04/20/2023
Event Type  Injury  
Manufacturer Narrative
The test strips were requested for investigation and have not been received at this time.If the product is returned in the future, a follow-up report will be submitted.  the reporter's meter was provided for investigation where it was tested using retention strips and retention controls.Testing results (qc range = 2.3 - 3.5 inr): qc 1: 2.9 inr.Qc 2: 2.8 inr.Qc 3: 2.9 inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and the results have passed the internal inspection.  per product labeling: "coaguchek method uses human recombinant thromboplastin.Therefore, the comparability to tests using other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastin types.However, those higher differences between thromboplastins of different (rabbit, bovine) origin are not an issue specific for coaguchek assays.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared with several other (rabbit, bovine) laboratory methods the investigation did not identify a product problem.The cause of the event could not be determined.  section e3 - occupation: patient/consumer h3 other text : na.
 
Event Description
We received an allegation of a questionable inr result for one patient tested with the coaguchek vantus serial number with serial number (b)(6) compared to an unknown laboratory method and that this meter may have contributed to a patient's blood clots in the heart.The reporter stated that his doctor advised him to go to the laboratory because he believes the meter readings were incorrect.The reporter stated on (b)(6) 2023, his doctor discovered blood clots in his heart while performing an ablation procedure.The reporter stated that the doctor stopped the procedure and will reschedule the procedure after the clots are dissolved with warfarin therapy.The reporter stated that the doctor said that the blood clots in his heart were due to his atrial fibrillation (a-fib) and atrial (a) flutter.The reporter stated that he is going to have a transesophageal echocardiogram procedure in 4 weeks to see if he still has the blood clots in his heart and needs his inr to be within the therapeutic range for the procedure.The meter result was 3.2 inr.The laboratory result using a venous sample was 1.9 inr. the reporter stated that he performed the meter test 15 minutes before going to the laboratory.The reporter stated that his doctor advised him to decrease his warfarin to.5 mg for 2 days.The patient's therapeutic range was reported to be 3.0-3.5 inr.    this mdr is being submitted with an abundance of caution.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key17007582
MDR Text Key315998360
Report Number1823260-2023-01754
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K170960
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 05/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/25/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number04625374160
Device Lot Number64708121
Date Manufacturer Received04/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
METOPROLOL.; WARFARIN.
Patient Outcome(s) Required Intervention; Other;
Patient Age76 YR
Patient SexMale
Patient Weight116 KG
-
-